← Back to catalogue

Mycoplasma genitalium macrolide resistance primers

FDA UDI

Class I (US FDA UDI)

by Diagenode

Identity

Trade Name
Mycoplasma genitalium macrolide resistance primers FDA UDI
Generic Name
Mycoplasma genitalium nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Oligonucleotides designed to detect the mutations associated to macrolide resistance on 23S RNA (A2058C, A2058G, A2058T, A2058C and A2059G) FDA UDI
Model / Reference
1 FDA UDI
Description
Oligonucleotides designed to detect the mutations associated to macrolide resistance on 23S RNA (A2058C, A2058G, A2058T, A2058C and A2059G) FDA UDI

Identifiers

Catalog Number
PRD-061107 FDA UDI
Primary DI / UDI-DI
15430001412069 FDA UDI
FDA Product Code
MVU FDA UDI
GMDN Term
Mycoplasma genitalium nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
864.4020 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Mycoplasma genitalium nucleic acid IVD, kit, nucleic acid technique (NAT)

Mycoplasma genitalium macrolide resistance primers by Diagenode — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Mycoplasma genitalium nucleic acid IVD, kit, nucleic acid technique (NAT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diagenode

Sources (1)

  • FDA UDI 198426a7-0b90-4170-a6d0-629ff6cc0e93 34 fields · synced May 31, 2026